U.S. Pharmacist Weekly News Update
May 8, 2019

Intensive BP Therapy Beneficial to T2D Patients at All CVD
Risk Levels

Pharmacists might be surprised to learn that even type 2 diabetes patients who aren’t at particularly high risk for cardiovascular disease (CVD) events or whose blood pressure isn’t that elevated appear to benefit from intensive antihypertensive therapy. Find out how researchers came to that determination.


Older Women Face Increased CVD Risks With Longer Term Antibiotic Usage
Pharmacists who refill longer term antibiotic prescriptions for older women might be especially interested in results of a new study: Researchers determined increased cardiovascular event risks in those patients. Find out which groups are affected and their risks.

Erectile Dysfunction Drugs Appear to Increase Some
Skin-Cancer Risk

Should men with erectile dysfunction avoid using certain medications because of a fear of increased skin-cancer risks? Probably not in most cases, according to a new database study that quantified the risks of malignant melanoma and basal cell carcinoma. Here are more details.

Thanks to Better Insurance Coverage, Depression Treatment Has Increased
Pharmacists have probably noticed, but insurance coverage is getting better for depression treatment. A new study looks at the prevalence of depression and spending for that care. Find out what percentage of patients use medication for the sometimes-debilitating condition.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App